NEW YORK, NY / ACCESSWIRE / April 29, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Align Technology, Inc. (NASDAQ:ALGN)

Investors Affected : April 24, 2019 – July 24, 2019

A class action has commenced on behalf of certain shareholders in Align Technology, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Align was then experiencing a significant decline in demand for its products in the important Chinese market; (b) Chinese consumer sentiment towards the Company was deteriorating; and (c) as a result of the foregoing, Defendants' positive statements about Align and its businesses were lacking in a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/align-technology-inc-loss-submission-form/?id=6253&from=1

XP Inc. (NASDAQ:XP)

Investors Affected : or otherwise acquired XP's securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with XP's December 2019 initial public offering.

A class action has commenced on behalf of certain shareholders in XP Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) XP engaged in undisclosed related party transactions; (2) XP failed to disclose its common and large system failures and connected losses; (3) XP's aggressive IFA strategy was and is tenuous; (4) XP had material weaknesses; (5) XP fired its previous accounting firm due to that firm finding and disclosing material weaknesses; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/xp-inc-loss-submission-form/?id=6253&from=1

eHealth, Inc. (NASDAQ:EHTH)

Investors Affected : March 19, 2018 – April 7, 2020

A class action has commenced on behalf of certain shareholders in eHealth, Inc. The complaint alleges that eHealth, Inc. issued materially false and/or misleading information and/or failed to disclose: (1) its highly aggressive accounting and modeling assumptions; (2) its skyrocketing rate of member churn, resulting from eHealth's pursuit of low quality, lossmaking growth; (3) its reliance on direct response television advertising, which attracts an unprofitable, high churn enrollee; and (4) that as a result of the foregoing, defendants' public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/ehealth-inc-loss-submission-form/?id=6253&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 587601

ASCOT, BERKSHIRE / ACCESSWIRE / April 29, 2020 / Ascot based businesses EIZO Limited and Lynda Yong have partnered with Frimley Health NHS Foundation Trust (FHFT) to produce an initial run of 8000+ PPE gowns for the NHS, in the midst of the Covid-19 pandemic.

The second floor of 1 Queens Square, Ascot Business Park, which is owned by specialist monitor manufacturer, EIZO Limited, has been transformed into a temporary sewing workshop. Starting its production today, the workshop is able to accommodate up to 25 sewers (socially distanced spaced to at least three metres apart) whose sole focus will be to produce some of the first PPE Gowns made in the UK. These gowns are vital in the protection of front-line NHS staff. The workshop space has been rented to the NHS and Lynda Yong for free by EIZO Limited in order to fulfil the current NHS order.

Having sourced PPE approved material from Bolton manufacturer TKX Insulations Excellence, the aim is to produce a minimum of 250 gowns per day, with daily deliveries to FHFT in order to fulfil the crucial need facing current NHS teams.

Colin Woodley, CEO of EIZO Limited explains "Colin Woodley, CEO of EIZO Limited explains "We bought 1 Queens Square, on Ascot Business Park, last year and initially the we developed the ground and first levels only with the second floor planned to be sublet later in the year. The large, open plan 4,800 sqft floor, has allowed for a rapid fit-out of all machinery and supplies needed to prepare the space, ready for production today. We are grateful to our partners that have helped us develop this amazing space in under 4 days. EIZO Limited has a long history of working with the NHS and we are pleased to be supporting them now by manufacturing something as vital as PPE Gowns, helping to keep NHS staff and their patients safe"

Callum Clark, Consultant Orthopaedic Surgeon who has been liaising and advising with the team at EIZO and Lynda on behalf of Frimley Health, comments, "The local Scrubs Glorious Scrubs campaign that Lynda initiated was a fantastic demonstration of how much the community is willing to help the NHS at this time, and down to her connections and drive, she has been able to source this material suitable for the needed PPE gowns.

"To now also be working with EIZO Limited, a local company is great for us and really ground breaking. Covid-19 looks like it could be with us for some time yet so including premises and skills from within our own community will help to ensure that that we have sufficient gowns for the future."

EIZO Limited

EIZO Limited, one of the UK's fastest growing monitor brands, is the UK based business of Japanese Visual Technology solutions company, EIZO Corporation. EIZO develops and manufactures high-end display solutions and has done so for over 50 years. The company integrates hardware and software technologies with consulting, web hosting and other services to help customers in business, healthcare, graphics, maritime, air traffic control and other fields work more comfortably.

During the Covid-19 pandemic crisis, EIZO Limited has been involved by offering its support to the local Scrubs Glorious Scrubs campaign, originally launched by Lynda Yong at The Fashion Workshop in Ascot. EIZO has donated 1000 metres of fabric to help support the production of scrubs for those hospitals local to its UK Headquarters in Ascot. It has also provided the necessary resources required to assist in the recruitment and message coordination to over 450 local volunteers who, collectively, are on track to produce over 2000 scrubs for the NHS. In addition, EIZO has supplied a number of its RadiForce medical, diagnostic monitors to support a national scale project enabling doctors to work and diagnose from home.

EIZO Limited has been providing medical grade monitors and other visual solutions equipment to both the NHS and Private Medical Sector in the UK since 2002. Over these 18 years, the EIZO name has become a leading supplier in the UK to the NHS and is already well-known to the professionals working within Radiology, Diagnostics, Mammography and OR to name but a few different hospital departments

EIZO Limited moved to Ascot Business Park in September 2019, to 1 Queens Square and currently resides on the first two floors, with its Customer Experiences Centre / product showroom, sales floor, Engineer Repair Centre and Warehouse.

Colin Woodley – CEO, EIZO Limited (available for comment)

Colin Woodley, CEO of EIZO Limited, has been working for the visual technology solutions business for over twenty years and has led the successful team since 2015. Since starting his current role, he has led the business through a change of radical growth, having seen the team and revenue more than double. In addition, Colin sits on the board of Directors for the Ascot Business Park as well as heading the team of school governors at his local primary school in Frimley. Colin aims to use his connections gained in both his personnel and professional to help bring people together and to make a difference.

The Fashion Workshop

The Fashion Workshop is an established alterations business in Ascot that has been providing a professional service for 35 years, owned and managed by established Couture Designer Lynda Yong.

Devoted clients include a number of international Royal Households, Heads of State and prominent figures in the Entertainment Industry.

A team of professional machinists and cutters work behind the scenes which is situated on the Ascot Business Park. All alteration work is carried out in-house.

Lynda Yong – The Fashion Workshop (available for comment)

Lynda Yong, is a qualified and skilled designer and dress maker. She started her professional life working for a design house, M. Glazers, in Watford. She has run her own made-to-measure business for over 35 years, and has a growing client list that includes royalty and many celebrities.

Scrubs Glorious Scrubs Campaign

Launched in April 2020 the Scrubs Glorious Scrubs campaign was set up by Lynda Yong in response to the NHS's plea of non-surgical scrubs needed urgently in the attempt to keep the NHS workers, their patients and families safe. Within two weeks, the collective included over 450 seamstresses all working to produce hats, trousers, tops and masks for the local Frimley Trust and surrounding surgeries and hospices. With a goal to create 2000 sets of scrubs, to date they are on track to fulfill this order within 3 weeks. The campaign has reached national status with press coverage in both local and national press, local and national TV,

as well as being supported by Virgin Radio DJ Chris Evans and family, Ross Kemp, Kirsty Gallacher. Scrubs have been produced by people of all ages (from 5-90!) and include those self-isolating at home, to royal designers.

1 Queens Square, Ascot Business Park

The new PPE gown production premises are based at 1 Queens Square, Ascot Business Park. A 14,200 square feet space, spread over three floors with 46 parking spaces and additional overflow parking on-site if required. The building owned by visual technology solutions company EIZO Limited accommodates both the ground and first floors. The ground floor consists of a welcoming reception area, a Customer Experience Centre showroom, a mock OR theatre, and three meeting rooms, while the first floor is used for all office staff. The EIZO / Fashion Workshop Alliance now occupies the second floor of the property.

Ascot Business Park

Ascot Business Park is adjacent to Ascot mainline rail station and 5 minutes' walk from Ascot High Street and Race Course, close to all local amenities, leisure facilities and situated close to Windsor

—————– ENDS —————–

NOTES TO EDITORS

For all Press Enquiries please contact:

Hayley Osborne

Head of Marketing and Communications

Hayley.Osborne@EIZO.com

Ø Further quotes and interviews, available upon request

Ø Photos can be downloaded using the following link: https://we.tl/t-DS9wOawrdu

Ø If using provided images, please ensure all are credited to photographer Katherine Woodley

Ø Please do not visit 1 Queens Square, Ascot without prior appointment

For further information:

EIZO Limited – www.eizo.co.uk / https://www.eizo.co.uk/healthcare/all-areas-of-application/

Lynda Yong / Fashion Workshop www.thefashionworkshop.com and www.lyndayong.com

Contacts

Hayley Osborne
Head of Marketing and Communications
hayley.osborne@Eizo.com
Mobile: 07733264126
www.eizo.co.uk

SOURCE: EIZO Limited

ReleaseID: 587588

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Canaan Inc. (NASDAQ:CAN)
Class Period: publicly traded securities of Canaan, including its American Depository Shares pursuant and/or traceable to the Company's registration statement and related prospectus issued in connection with the Company's November 20, 2019 initial public offering.
Lead Plaintiff Deadline: May 4, 2020

The complaint alleges that during the class period Canaan Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the purported "strategic cooperation" was actually a transaction with a related party; (2) the company's financial health was worse than what was actually reported; (3) the company had recently removed numerous distributors from its website just prior to the initial public offering, many of which were small or suspicious businesses; and (4) several of the Company's largest Chinese clients in prior years were clients who were not in the Bitcoin mining industry and, thus, would likely not be repeat customers.

Learn about your recoverable losses in CAN: http://www.kleinstocklaw.com/pslra-1/canaan-inc-loss-submission-form?id=6252&from=1

Tilray, Inc. (NASDAQ:TLRY)
Class Period: January 15, 2019 to March 2, 2020
Lead Plaintiff Deadline: May 5, 2020

The TLRY lawsuit alleges that throughout the class period, Tilray, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the purported advantages of the marketing and revenue sharing agreement with Authentic Brands Group (the "ABG Agreement")were significantly overstated; (ii) the under performance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in TLRY: http://www.kleinstocklaw.com/pslra-1/tilray-inc-loss-submission-form?id=6252&from=1

GSX Techedu Inc. (NYSE:GSX)
Class Period: June 6, 2019 to April 13, 2020
Lead Plaintiff Deadline: June 16, 2020

According to the complaint, GSX Techedu Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in GSX: http://www.kleinstocklaw.com/pslra-1/gsx-techedu-inc-loss-submission-form?id=6252&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 587597

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

WWE Shareholders Click Here: https://www.zlk.com/pslra-1/world-wrestling-entertainment-inc-loss-form?prid=6251&wire=1
CRON Shareholders Click Here: https://www.zlk.com/pslra-1/cronos-group-inc-loss-form-2?prid=6251&wire=1
IQ Shareholders Click Here: https://www.zlk.com/pslra-1/iqiyi-inc-loss-form?prid=6251&wire=1

* ADDITIONAL INFORMATION BELOW *

World Wrestling Entertainment, Inc. (NYSE:WWE)

WWE Lawsuit on behalf of: investors who purchased February 7, 2019 – February 5, 2020
Lead Plaintiff Deadline : May 5, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/world-wrestling-entertainment-inc-loss-form?prid=6251&wire=1

According to the filed complaint, during the class period, World Wrestling Entertainment, Inc. made materially false and/or misleading statements and/or failed to disclose that: Defendants perpetrated a fraudulent scheme which: (i) deceived the investing public regarding WWE's business and prospects; (ii) artificially inflated the price of WWE Class A common stock; (iii) permitted certain senior executives of WWE to sell more than $282 million worth of their personally held shares at fraud inflated prices; and (iv) caused the public to purchase WWE Class A common stock at artificially inflated prices.

Cronos Group Inc. (NASDAQ:CRON)

CRON Lawsuit on behalf of: investors who purchased May 9, 2019 – March 2, 2020
Lead Plaintiff Deadline : May 11, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cronos-group-inc-loss-form-2?prid=6251&wire=1

According to the filed complaint, during the class period, Cronos Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (ii) the foregoing would foreseeably necessitate reviews that would delay the Company's ability to timely file its periodic reports; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

iQIYI, Inc. (NASDAQ:IQ)

IQ Lawsuit on behalf of: investors who purchased March 29, 2018 – April 7, 2020
Lead Plaintiff Deadline : June 15, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/iqiyi-inc-loss-form?prid=6251&wire=1

According to the filed complaint, during the class period, iQIYI, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) iQIYI inflated its revenue figures; (2) iQIYI inflated its user numbers; (3) iQIYI inflated its expenses to cover up other fraud; and (4) as a result, Defendants' public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 587596

The Work of Gabriel Btesh is Showing Its True Value in the Age of the Coronavirus.

PANAMA CITY, PANAMA / ACCESSWIRE / April 29, 2020 / It was a family business that was the foundation, the role of construction that was the tool, and Gabriel Gaby Btesh was the man behind the change. Now that change is being realized in his home of Panama City, and beyond. It is also in the age of the coronavirus that his words, which have almost become his mission statement, reveal their true value.

As the pandemic continues to threaten the safety of people and their way of life, it is because of his work that so many can endure these trying days, more comfortably and safely. In his own words, Gabriel Btesh has said, "I've long been an advocate for the improvements being made surrounding accelerating standards of living and well-being… and on a scale as great as possible."

That scale has been great indeed. In the period of a few short decades, Gabriel Btesh has been given credit for much of the change in Panama City, from improved housing to contributing to job creation and the Republic's economic growth.

The housing sector and housing developments were the early focus of his business, providing a better, safer, and a higher standard and quality of life. That success soon propelled Gabriel Btesh to expand his company's construction efforts into the arena of commercial business like the entertainment and leisure sectors. Those latter endeavors have been responsible for the creation of "…tens of thousands of jobs," as Gabriel Btesh proudly says.

Since taking the helm of his father's construction company, Gabriel Btesh has spent more than three decades investing in the people, the well-being, and the business of Panama City. That investment has been evident in his commitment to providing improved and better housing options for lower-income and young families.

While these accomplishments have given Gabriel Btesh a platform as a leader in socially conscious construction, his work is far from over. Today, Gabriel Btesh is investing in other construction companies who seek to follow his success and socially conscious example.

As a mentor, Gabriel Btesh is now helping others in the construction industry. As a philanthropist, he has focused his time, efforts, and attention on the housing needs of the less-privileged. Gabriel Gaby Btesh continues the legacy of Btesh Construction, and he is doing it by building more than homes.

CONTACT:
Caroline Hunter
Web Presence, LLC
+1 786-233-8220

SOURCE: Web Presence

ReleaseID: 587595

Major oxalic acid manufacturers are focusing on innovations in water treatment and pharmaceutical applications driven by demand for sterilization and hygiene from the healthcare industry.

DUBAI, UAE / ACCESSWIRE / April 29, 2020 / The global oxalic acid market will cross a value pool of US$ 1Bn through the end of 2029. According to a new study by Future Market Insights (FMI), the market for oxalic acid is largely influenced by increasing applications in domestic, institutional, and industrial chemicals. The industry is also supported by growth in worldwide industrial output and growing concerns over the efficacy of water treatment processes.

"Factors such as changing food habits, lifestyles, and sleeping habits are contributing to the demand for pharmaceuticals across the globe. This in turn, is leading to the growing consumption of oxalic acid," reveals the FMI report.

Request report sample with 250+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-1267

Key Research Findings

On the basis of type, standard grade oxalic acid will account for more than 40% of the overall revenue share through the forecast period, gradually losing out to technical grade variants.
Applications as bleaching or purifying agents will hold major market share, while the uses as reducing agents will display a higher growth rate.
Widespread adoption in activities in the petrochemical industry, will lead the market in terms of end user applications.
Gains of the global oxalic acid market will remain largely concentrated in East Asia. This market will display very lucrative opportunities, driven by the industrial sector and lax regulations.

Key Growth Drivers

Strong concerns over sterilization requirements for pharmaceutical equipment plays a key role in the growth of the market.
Widespread use of digital technologies in pharmaceutical and rare earth industries to add to the global footprint of players.
Extensive use of oxalic acid for industrial and domestic cleaning and bleaching agents is a major factor contributing to market growth.
The rising varieties of medical equipment, and applications in water treatment will drive adoption.

Key Impediments

The oxalic acid market faces continued challenges owing to health risks and side effects associated with unprotected exposure to the material, which can hamper market growth.

The Covid-19 Impact

For oxalic acid, China is a key manufacturing center for raw materials. As the number of coronavirus cases in the region decline, production levels have started to recover. On the other hand, lack of adequate manpower, and disruptions in supply chains will result in a slow recovery to full efficiency in production. Further, volatility in prices and reduced rates of adoption in end user industries will minimize value creation. In addition, logistical hurdles and travel restrictions set up by governments around the world will hamper market growth in the short term.

Explore the complete oxalic acid market report with 135 illustrative figures, 40 data tables, and the table of contents. Also find a detailed market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-1267

Competition Structure Analysis – Oxalic acid Market

The competition landscape of oxalic acid market remains fairly fragmented. Key players are also investing in collaborations with government bodies and end user industries. Players are also focusing their efforts towards bolstering their direct presence in the local markets of emerging economies to leverage untapped market potential.

Some of the key players in the oxalic acid market include, but are not limited to Penta s.r.o., Mundanjiang Fengda Chemical Co. Ltd., Shandong Fengyuan Chemical Co. Ltd., Oxaquim, Spectrum Chemical Manufacturing Corp., Merck KGaA, Shijiazhuang Taihe Chemical Co. Ltd., UBE Industries Ltd., Indian Oxalate Ltd., and Clariant International Ltd.

Explore Future Market Insights' detailed coverage on,

Acrylic Fiber Market– This research report provides an exhaustive range of insights which identify revenue sectors, essential strategies, and major growth opportunities, associated with acrylic fiber products.

Fertilizer Additives Market– This report includes a detailed analysis on competitive scenarios, and essential information on major players in the fertilizer additives market.

Propyl Acetate Market– This write up encompasses detailed secondary research, which is used to estimate key industry players, overall size of the propyl acetate market, and relevant industry associations.

Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solutions to solve the complex strategy challenges that organizations face today.

About the Report

This report offers global, regional, and national level analysis on the latest trends in the industry influencing the oxalic acid market. The study provides actionable insights on the oxalic acid market on the basis of grade (standard grade, technical/pharma grade, and electronic/food grade), application (bleaching & purifying agents, reducing agents, stain & rust removers, miticide, precipitation agents, and others), and end use (petrochemicals, water treatment chemicals, metallurgy, textiles & leather, pharmaceuticals, electronics & semiconductors, food, wood pulp, and bee-hiving) across 30 countries spanning seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/oxalic-acid-market
Press Release Source: https://www.futuremarketinsights.com/press-release/oxalic-acid-market

SOURCE: Future Market Insights

ReleaseID: 587568

TORONTO, ON / ACCESSWIRE / April 29, 2020 / GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) ("GlobeX" or the "Company"), the leader in Swiss hosted cyber security and Internet privacy solutions for secure data management and secure communications, is pleased to announce that it has launched a new Synchronized Data Backup and Recovery feature as part of its DigitalSafe secure cloud document management and business productivity solution.

The new proprietary Synchronized Data Backup feature is aimed at backing up any file or folder sitting on a local device, into GlobeX's secure Swiss hosted cloud infrastructure. The technology uses anti-malware and anti-virus, as well as the Company's VirtualVaults encrypted technology. The feature automatically backs up any file or folder designated on a user's computer and updates automatically as changes and updates are added to the file or folder. The system comes with versioning and unlimited uploads. The feature is currently available for Mac Operating System and will be available for Windows OS by Q3 2020.

According to a study published by researchandmarkets.com, the data backup and recovery market is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period owing to growing amount of data and increasing adoption of cloud data backup solutions. The global data backup and recovery market size is expected to grow to USD 11.59 billion by 2022, at a CAGR of 10.2% during the forecast period. Data backup and recovery software and solutions play a vital role to protect, replicate, and retain data in case of any manual or natural disaster.

With the new Synchronized feature embedded in DigitalSafe, the Company will be able to compete with all other US based data backup software and offer the benefit of Swiss data privacy to its users. The Company anticipates an increase in demand from businesses looking to guarantee the privacy and security of their data with GlobeX's VirtualVaults and HeliX proprietary technology and its Swiss hosting, benefiting from Swiss data privacy laws.

Alain Ghiai, CEO of GlobeX Data said: "We are very excited to add this feature to our DigitalSafe secure cloud document management and collaboration suite. Now that we can backup unlimited files and folders and store them safely in our Swiss vaults, we can offer a complete solution to businesses and enterprises that encompasses all their needs and protects their entire data with Swiss privacy laws applied. This will increase our appeal dramatically and we look forward to offer this Swiss vault for businesses of all sizes and individual consumers. Data is critical for any business, and we can now make sure it is stored in Switzerland, in a safe and private data center for them at the click of a mouse."

About GlobeX Data Ltd.
GlobeX Data Ltd. is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure data management and secure communications. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted e-mails, and secure communication tools. GlobeX Data Ltd. sells its products through its approved wholesalers and distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses and governments worldwide.

On behalf of Management

GLOBEX DATA LTD.

Alain Ghiai
President and Chief Executive Officer
+1.416.644.8690
corporate@globexdatagroup.com

For more information please contact GlobeX Data at corporate@globexdatagroup.com or visit us at https://globexdatagroup.com.
For more information on DigitalSafe visit us at: https://digitalsafe.com.

Forward Looking Information
This news release contains certain forward-looking information within the meaning of applicable Canadian securities laws ("forward-looking statements"). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "outlook", "expect", "project" and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. GlobeX cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond GlobeX's control. Such factors include, among other things: risks and uncertainties relating to the future of the Company's business; the success of marketing and sales efforts of the Company; the projections prepared in house and projections delivered by channel partners; the Company's ability to complete the necessary software updates; increases in sales as a result of investments software development technology; consumer interest in the Products; future sales plans and strategies; reliance on large channel partners and expectations of renewals to ongoing agreements with these partners; anticipated events and trends; the economy and other future conditions; and other risks and uncertainties, including those described in GlobeX's prospectus dated May 8, 2019 filed with the Canadian Securities Administrators and available on www.sedar.com. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, GlobeX undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: GlobeX Data Ltd.

ReleaseID: 587584

Major lacrimal duct stent tube manufacturers are focusing on minimally invasive DCR procedures to bolster adoption rates through hospitals, outpatient clinics, and ambulatory surgical centers.

DUBAI, UAE / ACCESSWIRE / April 29, 2020 / The global lacrimal duct stent tube market will display a promising 6% CAGR through the forecast period 2019 – 2029. According to a new study by Future Market Insights (FMI), the market for lacrimal duct stent tube is largely influenced by the expenditure on healthcare, and a widening pool of patients suffering from nasolacrimal duct obstruction. The growing popularity of non-invasive surgeries will also contribute to growth.

"Improved success rates, minimally invasive surgery, superior outcomes, and increasing awareness among ophthalmologists are key factors bolstering growth in the lacrimal duct stent tube market," reveals the FMI report.

Request report sample with 250+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

Key Research Findings

On the basis of type, bicanalicular lacrimal duct stent tube will account for three quarters of the overall revenue share through the forecast period.
Hospitals will hold a larger market share through the forecast period, followed closely by ophthalmic clinics.
Gains of the global lacrimal duct stent tube market will remain largely concentrated in North America, driven by expanding numbers of retinal disease cases.
The East Asia Market will display lucrative opportunities, driven by the rising number of relevant health professionals.

Key Growth Drivers

The growing patient pool and rising expenditure on the healthcare sector play major roles in the growth of market.
Advancements and the growing demand for non-invasive surgeries add to the global footprint of players.
Increasing global incidences of retinal diseases is a major factor contributing to market growth.
The rising promotional activities about nasolacrimal duct obstruction management for health care professionals will drive adoption.

Key Impediments

The risk of corneal abrasion from treatment procedures continues to be a key restraint to the global market.
Risk of complications among patients of younger demographics, could hamper the potential market growth.

The Coronavirus Impact

Governments around the world have set up financial relief packages for healthcare professionals being impacted by the global coronavirus pandemic. However, guidelines have also been encouraging doctors to stop providing all treatments of a non-urgent nature, for the foreseeable future, till the outbreak is brought under control.

This trend is likely to hamper the global market for lacrimal duct stent tubes in the near future. The decline in demand will impact profits and production schedules in the months ahead. With advances in ophthalmology tech, recovery of the industry is likely to be sluggish in the near future, as countries seek to conserve their medical supply stocks, for applications that have a higher priority.

Explore the complete lacrimal duct stent tube market report with 119 illustrative figures, 38 data tables, and the table of contents. Also find a detailed market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-9649

Competition Structure Analysis – Lacrimal Duct Stent Tube Market

The competition landscape of lacrimal duct stent tube market remains moderately consolidated. Key players are investing in research and development activities in a bid to bolster product development to meet patient needs with better outcomes. Innovations towards treating dacryocystorhinostomy (DCR), and congenital nasolacrimal duct obstruction (CNLDO) remain major strategies.

Some of the key players in the lacrimal duct stent tube market include, but are not limited to Bess Medizintechnik Gmbh, FCI Opthalmics, Gunther Weiss Scientific Glass, and Kaneka Corporation.

Explore Future Market Insights' detailed coverage on,

Special Purpose Needles Market– This research report provides an exhaustive range of insights which identify essential revenue sectors, key strategies, and major growth opportunities, associated with special purpose needles.

Renal Biomarker Market– This report includes a detailed analysis on competitive scenarios, and essential information on major players in the renal biomarker market.

Clinical Oncology Next Generation Sequencing Market – This write up encompasses detailed secondary research, which is used to estimate key industry players, overall size of the professional clinical oncology next generation sequencing market, and relevant industry associations.

Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solutions to solve the complex strategy challenges that organizations face today.

About the Report

This report offers global, regional, and national level analysis on the latest trends in the industry influencing the lacrimal duct stent tube market. The study provides actionable insights on the lacrimal duct stent tube market on the basis of product (monocanalicular lacrimal duct stent tube and bicanalicuar lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, and ambulatory surgical centers) across 30 countries spanning seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/lacrimal-devices-market
Press Release Source: https://www.futuremarketinsights.com/press-release/lacrimal-devices-market

SOURCE: Future Market Insights

ReleaseID: 587570

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Tufin Software Technologies Ltd. (NYSE:TUFN)

Investors Affected : securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Tufin's April 2019 initial public offering

A class action has commenced on behalf of certain shareholders in Tufin Software Technologies Ltd. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Tufin's customer relationships and growth metrics were overstated, particularly with respect to North America; (2) Tufin's business was deteriorating, primarily in North America; (3) as a result, Tufin's representations regarding its sustainable financial prospects were overly optimistic; and (4) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.

Shareholders may find more information at https://securitiesclasslaw.com/securities/tufin-software-technologies-ltd-loss-submission-form/?id=6249&from=1

Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

Investors Affected : February 14, 2020 – March 9, 2020

A class action has commenced on behalf of certain shareholders in Inovio Pharmaceuticals, Inc. According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

Shareholders may find more information at https://securitiesclasslaw.com/securities/inovio-pharmaceuticals-inc-loss-submission-form/?id=6249&from=1

Zoom Video Communications, Inc. (NASDAQ:ZM)

Investors Affected : April 18, 2019 – April 6, 2020

A class action has commenced on behalf of certain shareholders in Zoom Video Communications, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Zoom had inadequate data privacy and security measures; (ii) contrary to Zoom's assertions, the Company's video communications service was not end-to-end encrypted; (iii) as a result of all the foregoing, users of Zoom's communications services were at an increased risk of having their personal information accessed by unauthorized parties, including Facebook; (iv) usage of the Company's video communications services was foreseeably likely to decline when the foregoing facts came to light; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/zoom-video-communications-inc-loss-submission-form/?id=6249&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 587579

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

CAN Shareholders Click Here: https://www.zlk.com/pslra-1/canaan-inc-loss-form?prid=6248&wire=1
MESA Shareholders Click Here: https://www.zlk.com/pslra-1/mesa-air-group-incorporated-loss-form?prid=6248&wire=1
GSX Shareholders Click Here: https://www.zlk.com/pslra-1/gsx-techedu-inc-loss-form?prid=6248&wire=1

* ADDITIONAL INFORMATION BELOW *

Canaan Inc. (NASDAQ:CAN)

CAN Lawsuit on behalf of: investors who purchased publicly traded securities of Canaan, including its American Depository Shares pursuant and/or traceable to the Company's registration statement and related prospectus issued in connection with the Company's November 20, 2019 initial public offering.
Lead Plaintiff Deadline : May 4, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/canaan-inc-loss-form?prid=6248&wire=1

According to the filed complaint, (1) the purported "strategic cooperation" was actually a transaction with a related party; (2) the company's financial health was worse than what was actually reported; (3) the company had recently removed numerous distributors from its website just prior to the initial public offering, many of which were small or suspicious businesses; and (4) several of the Company's largest Chinese clients in prior years were clients who were not in the Bitcoin mining industry and, thus, would likely not be repeat customers.

Mesa Air Group Incorporated (NASDAQ:MESA)

MESA Lawsuit on behalf of: investors who purchased shares pursuant and/or traceable to the documents issued in connection with Mesa Air Group's August 2018 initial public offering.
Lead Plaintiff Deadline : June 1, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/mesa-air-group-incorporated-loss-form?prid=6248&wire=1

According to the filed complaint, (1) Mesa Air Group's operational performance was poor and below industry standards; (2) Mesa Air Group had a shortage of qualified mechanics and maintenance personnel; (3) Mesa Air Group had an inadequate number of spare aircraft and parts; (4) Mesa Air Group did not have a strong track record of reliable performance; (5) then-existing "risks" had already materialized; (6) Mesa Air Group knew of undisclosed adverse trends and uncertainties at the time of the initial public offering; and (7) as a result, Defendants' public statements were materially false and misleading at all relevant times.

GSX Techedu Inc. (NYSE:GSX)

GSX Lawsuit on behalf of: investors who purchased June 6, 2019 – April 13, 2020
Lead Plaintiff Deadline : June 16, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/gsx-techedu-inc-loss-form?prid=6248&wire=1

According to the filed complaint, during the class period, GSX Techedu Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 587576